1. Home
  2. GAME vs NTRB Comparison

GAME vs NTRB Comparison

Compare GAME & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameSquare Holdings Inc.

GAME

GameSquare Holdings Inc.

HOLD

Current Price

$0.44

Market Cap

43.4M

Sector

N/A

ML Signal

HOLD

Logo Nutriband Inc.

NTRB

Nutriband Inc.

HOLD

Current Price

$3.23

Market Cap

42.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAME
NTRB
Founded
2011
2016
Country
United States
United States
Employees
N/A
3
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.4M
42.4M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
GAME
NTRB
Price
$0.44
$3.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.4M
9.8K
Earning Date
04-08-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
65.14
N/A
EPS
N/A
N/A
Revenue
$44,999,302.00
N/A
Revenue This Year
$87.12
$30.17
Revenue Next Year
$21.14
$3,394.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$2.90
52 Week High
$2.87
$11.68

Technical Indicators

Market Signals
Indicator
GAME
NTRB
Relative Strength Index (RSI) 51.87 30.99
Support Level $0.44 N/A
Resistance Level $0.49 $3.67
Average True Range (ATR) 0.04 0.16
MACD 0.00 -0.04
Stochastic Oscillator 51.74 0.00

Price Performance

Historical Comparison
GAME
NTRB

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is a vertically integrated digital media, entertainment, and technology company focused on gaming and youth culture audiences. The company operates through four reportable segments: Owned and Operated IP, Agency, SaaS and managed services, and Yield. It provides services including influencer marketing, esports talent management, creative production, merchandise and consumer products, live streaming analytics, and digital media solutions through its various brands and platforms. It generates the majority of its revenue from the Agency segment.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: